Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Equity (2021 - 2025)

Historic Return on Equity for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to 0.03%.

  • Cytek Biosciences' Return on Equity fell 100.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.02% for FY2024, which is 100.0% up from last year.
  • Per Cytek Biosciences' latest filing, its Return on Equity stood at 0.03% for Q3 2025, which was down 100.0% from 0.02% recorded in Q2 2025.
  • Cytek Biosciences' 5-year Return on Equity high stood at 0.05% for Q3 2021, and its period low was 0.05% during Q2 2024.
  • For the 5-year period, Cytek Biosciences' Return on Equity averaged around 0.01%, with its median value being 0.02% (2024).
  • As far as peak fluctuations go, Cytek Biosciences' Return on Equity plummeted by -600bps in 2022, and later soared by 300bps in 2025.
  • Over the past 5 years, Cytek Biosciences' Return on Equity (Quarter) stood at 0.01% in 2021, then dropped by -21bps to 0.01% in 2022, then plummeted by -612bps to 0.03% in 2023, then soared by 49bps to 0.02% in 2024, then crashed by -120bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.02% for Q2 2025, and 0.03% during Q1 2025.